Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Table 3 Distribution of disease-modifying antirheumatic drug in 100 rheumatoid arthritis patients

From: Serum cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction

  Disease-modifying antirheumatic drug
  None Methotrexate Leflunomide Sulfasalazopyrine Gold Chloroquine Others
Number 22 42 10 10 6 4 6